{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T04:27:31Z","timestamp":1779251251731,"version":"3.51.4"},"reference-count":59,"publisher":"Impact Journals, LLC","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncotarget"],"published-print":{"date-parts":[[2025,8,29]]},"DOI":"10.18632\/oncotarget.28764","type":"journal-article","created":{"date-parts":[[2025,8,29]],"date-time":"2025-08-29T15:00:07Z","timestamp":1756479607000},"page":"681-696","source":"Crossref","is-referenced-by-count":3,"title":["<i>In vivo<\/i> manipulation of the protein homeostasis network in rhabdomyosarcoma"],"prefix":"10.18632","volume":"16","author":[{"given":"Kristen","family":"Kwong","sequence":"first","affiliation":[{"name":"Department of Pediatrics, Division of Oncology, University of California San Francisco, San Francisco, CA 94143, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yue","family":"Pan","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Division of Oncology, University of California San Francisco, San Francisco, CA 94143, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacqueline","family":"Morales","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Division of Oncology, University of California San Francisco, San Francisco, CA 94143, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew","family":"Watson","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Division of Oncology, University of California San Francisco, San Francisco, CA 94143, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David V.","family":"Allegakoen","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Division of Oncology, University of California San Francisco, San Francisco, CA 94143, USA"},{"name":"Department of Pediatrics, Georgetown University, Washington, DC 20057, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alex G.","family":"Lee","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Division of Oncology, University of California San Francisco, San Francisco, CA 94143, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Trever G.","family":"Bivona","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Hematology-Oncology, University of California San Francisco, San Francisco, CA 94143, USA"},{"name":"Chan Zuckerberg Biohub, San Francisco, CA 94158, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Wipf","sequence":"additional","affiliation":[{"name":"Department of Chemistry, University of Pittsburgh, Pittsburgh, PA 15260, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher J.","family":"Guerriero","sequence":"additional","affiliation":[{"name":"Department of Biological Sciences, University of Pittsburgh, Pittsburgh, PA 15260, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeffrey L.","family":"Brodsky","sequence":"additional","affiliation":[{"name":"Department of Biological Sciences, University of Pittsburgh, Pittsburgh, PA 15260, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amit J.","family":"Sabnis","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Division of Oncology, University of California San Francisco, San Francisco, CA 94143, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"7892","published-online":{"date-parts":[[2025,8,29]]},"reference":[{"key":"1","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1200\/JCO.2015.63.4048","article-title":"Intensive Multiagent Therapy, Including Dose-Compressed Cycles of Ifosfamide\/Etoposide and Vincristine\/Doxorubicin\/Cyclophosphamide, Irinotecan, and Radiation, in Patients With High-Risk Rhabdomyosarcoma: A Report From the Children\u2019s Oncology Group","volume":"3","author":"Arndt","year":"2016","journal-title":"J Clin Oncol"},{"key":"2","doi-asserted-by":"publisher","first-page":"6437","DOI":"10.1002\/cam4.2504","article-title":"Refinement of risk stratification for childhood rhabdomyosarcoma using FOXO1 fusion status in addition to established clinical outcome predictors: A report from the Children\u2019s Oncology Group","volume":"8","author":"Arndt","year":"2019","journal-title":"Cancer Med"},{"key":"3","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1083\/jcb.201612111","article-title":"Shaping proteostasis at the cellular, tissue, and organismal level","volume":"21","author":"Morimoto","year":"2017","journal-title":"J Cell Biol"},{"key":"4","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1016\/j.cell.2009.02.024","article-title":"Principles of cancer therapy: oncogene and non-oncogene addiction","volume":"13","author":"Elledge","year":"2009","journal-title":"Cell"},{"key":"5","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1158\/1535-7163.MCT-12-0782","article-title":"Endoplasmic reticulum stress and the unfolded protein response: targeting the Achilles heel of multiple myeloma","volume":"1","author":"Samali","year":"2013","journal-title":"Mol Cancer Ther"},{"key":"6","doi-asserted-by":"publisher","first-page":"jcs217760","DOI":"10.1242\/jcs.217760","article-title":"Compensatory increases of select proteostasis networks after Hsp70 inhibition in cancer cells","volume":"13","author":"Brodsky","year":"2018","journal-title":"J Cell Sci"},{"key":"7","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1038\/s41580-020-0250-z","article-title":"Mechanisms, regulation and functions of the unfolded protein response","volume":"2","author":"Kaufman","year":"2020","journal-title":"Nat Rev Mol Cell Biol"},{"key":"8","doi-asserted-by":"publisher","first-page":"2385","DOI":"10.3390\/cancers12092385","article-title":"Proteotoxic Stress and Cell Death in Cancer Cells","volume":"1","author":"Iuliano","year":"2020","journal-title":"Cancers (Basel)"},{"key":"9","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1016\/j.ccr.2013.11.002","article-title":"Targeting oxidative stress in embryonal rhabdomyosarcoma","volume":"2","author":"Valentine","year":"2013","journal-title":"Cancer Cell"},{"key":"10","doi-asserted-by":"publisher","first-page":"9015","DOI":"10.1073\/pnas.1603883113","article-title":"Combined chemical-genetic approach identifies cytosolic HSP70 dependence in rhabdomyosarcoma","volume":"11","author":"Wipf","year":"2016","journal-title":"Proc Natl Acad Sci U S A"},{"key":"11","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1126\/science.1209038","article-title":"The unfolded protein response: from stress pathway to homeostatic regulation","volume":"33","author":"Ron","year":"2011","journal-title":"Science"},{"key":"12","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/j.molcel.2017.10.028","article-title":"VCP\/p97-Mediated Unfolding as a Principle in Protein Homeostasis and Signaling","volume":"6","author":"Meyer","year":"2018","journal-title":"Mol Cell"},{"key":"13","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1007\/978-3-030-28151-9_7","article-title":"Structure and Function of the AAA+ ATPase p97, a Key Player in Protein Homeostasis","volume":"9","author":"Schindelin","year":"2019","journal-title":"Subcell Biochem"},{"key":"14","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.chembiol.2022.12.007","article-title":"Inhibitors of the ATPase p97\/VCP: From basic research to clinical applications","volume":"3","author":"Ramadan","year":"2023","journal-title":"Cell Chem Biol"},{"key":"15","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1038\/s41580-019-0133-3","article-title":"The Hsp70 chaperone network","volume":"2","author":"Bukau","year":"2019","journal-title":"Nat Rev Mol Cell Biol"},{"key":"16","doi-asserted-by":"publisher","first-page":"51131","DOI":"10.1074\/jbc.M404857200","article-title":"Small molecule modulators of endogenous and co-chaperone-stimulated Hsp70 ATPase activity","volume":"27","author":"Brodsky","year":"2004","journal-title":"J Biol Chem"},{"key":"17","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1021\/cb1000422","article-title":"Binding of a small molecule at a protein-protein interface regulates the chaperone activity of hsp70-hsp40","volume":"5","author":"Gestwicki","year":"2010","journal-title":"ACS Chem Biol"},{"key":"18","doi-asserted-by":"publisher","first-page":"6757","DOI":"10.1073\/pnas.1015251108","article-title":"Chemical methodology as a source of small-molecule checkpoint inhibitors and heat shock protein 70 (Hsp70) modulators","volume":"10","author":"Wipf","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"19","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1038\/nrm2941","article-title":"The HSP70 chaperone machinery: J proteins as drivers of functional specificity","volume":"1","author":"Craig","year":"2010","journal-title":"Nat Rev Mol Cell Biol"},{"key":"20","doi-asserted-by":"publisher","first-page":"W449","DOI":"10.1093\/nar\/gku476","article-title":"LINCS Canvas Browser: interactive web app to query, browse and interrogate LINCS L1000 gene expression signatures","volume":"4","author":"Ma\u2019ayan","year":"2014","journal-title":"Nucleic Acids Res"},{"key":"21","doi-asserted-by":"publisher","first-page":"W697","DOI":"10.1093\/nar\/gkac328","article-title":"SigCom LINCS: data and metadata search engine for a million gene expression signatures","volume":"5","author":"Ma\u2019ayan","year":"2022","journal-title":"Nucleic Acids Res"},{"key":"22","doi-asserted-by":"publisher","first-page":"168418","DOI":"10.1016\/j.jmb.2023.168418","article-title":"The Essential Functions of Molecular Chaperones and Folding Enzymes in Maintaining Endoplasmic Reticulum Homeostasis","volume":"43","author":"Brodsky","year":"2024","journal-title":"J Mol Biol"},{"key":"23","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1146\/annurev.biochem.73.011303.074134","article-title":"The mammalian unfolded protein response","volume":"7","author":"Kaufman","year":"2005","journal-title":"Annu Rev Biochem"},{"key":"24","doi-asserted-by":"publisher","first-page":"a033894","DOI":"10.1101\/cshperspect.a033894","article-title":"Early Events in the Endoplasmic Reticulum Unfolded Protein Response","volume":"1","author":"Ron","year":"2019","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"25","doi-asserted-by":"publisher","first-page":"105182","DOI":"10.1016\/j.jbc.2023.105182","article-title":"Structural insights of the p97\/VCP AAA+ ATPase: How adapter interactions coordinate diverse cellular functionality","volume":"29","author":"Southworth","year":"2023","journal-title":"J Biol Chem"},{"key":"26","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.ceb.2018.04.004","article-title":"Mechanistic insights into ER-associated protein degradation","volume":"5","author":"Rapoport","year":"2018","journal-title":"Curr Opin Cell Biol"},{"key":"27","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1038\/s41589-020-00726-x","article-title":"VCP\/p97 regulates Beclin-1-dependent autophagy initiation","volume":"1","author":"Rubinsztein","year":"2021","journal-title":"Nat Chem Biol"},{"key":"28","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1016\/j.tibs.2020.12.013","article-title":"ER-Phagy, ER Homeostasis, and ER Quality Control: Implications for Disease","volume":"4","author":"Brodsky","year":"2021","journal-title":"Trends Biochem Sci"},{"key":"29","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.1152\/physrev.00038.2021","article-title":"ER-phagy: mechanisms, regulation, and diseases connected to the lysosomal clearance of the endoplasmic reticulum","volume":"10","author":"Molinari","year":"2022","journal-title":"Physiol Rev"},{"key":"30","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1016\/j.cell.2017.06.010","article-title":"Defining a Cancer Dependency Map","volume":"17","author":"Goodale","year":"2017","journal-title":"Cell"},{"key":"31","doi-asserted-by":"publisher","first-page":"9480","DOI":"10.1021\/acs.jmedchem.5b01346","article-title":"Discovery of a First-in-Class, Potent, Selective, and Orally Bioavailable Inhibitor of the p97 AAA ATPase (CB-5083)","volume":"5","author":"Kumar","year":"2015","journal-title":"J Med Chem"},{"key":"32","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1016\/j.ccell.2015.10.002","article-title":"Targeting the AAA ATPase p97 as an Approach to Treat Cancer through Disruption of Protein Homeostasis","volume":"2","author":"Menon","year":"2015","journal-title":"Cancer Cell"},{"key":"33","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1124\/jpet.120.000486","article-title":"A p97\/Valosin-Containing Protein Inhibitor Drug CB-5083 Has a Potent but Reversible Off-Target Effect on Phosphodiesterase-6","volume":"37","author":"Vargas","year":"2021","journal-title":"J Pharmacol Exp Ther"},{"key":"34","doi-asserted-by":"publisher","first-page":"1892","DOI":"10.1021\/acs.jmedchem.9b01318","article-title":"p97: An Emerging Target for Cancer, Neurodegenerative Diseases, and Viral Infections","volume":"6","author":"Wipf","year":"2020","journal-title":"J Med Chem"},{"key":"35","doi-asserted-by":"publisher","first-page":"eabg1168","DOI":"10.1126\/scitranslmed.abg1168","article-title":"Targeting acute myeloid leukemia dependency on VCP-mediated DNA repair through a selective second-generation small-molecule inhibitor","volume":"1","author":"Pikman","year":"2021","journal-title":"Sci Transl Med"},{"key":"36","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1021\/acsmedchemlett.3c00163","article-title":"Optimization of 1,2,4-Triazole-Based p97 Inhibitors for the Treatment of Cancer","volume":"1","author":"Li","year":"2023","journal-title":"ACS Med Chem Lett"},{"key":"37","doi-asserted-by":"publisher","first-page":"2375","DOI":"10.1158\/1535-7163.MCT-17-0233","article-title":"The p97 Inhibitor CB-5083 Is a Unique Disrupter of Protein Homeostasis in Models of Multiple Myeloma","volume":"1","author":"Yao","year":"2017","journal-title":"Mol Cancer Ther"},{"key":"38","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1007\/978-3-030-40204-4_10","article-title":"Lessons Learned from Proteasome Inhibitors, the Paradigm for Targeting Protein Homeostasis in Cancer","volume":"124","author":"Wiita","year":"2020","journal-title":"Adv Exp Med Biol"},{"key":"39","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/j.ydbio.2015.03.001","article-title":"The Childhood Solid Tumor Network: A new resource for the developmental biology and oncology research communities","volume":"41","author":"Dyer","year":"2016","journal-title":"Dev Biol"},{"key":"40","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1101\/gad.12.7.982","article-title":"CHOP is implicated in programmed cell death in response to impaired function of the endoplasmic reticulum","volume":"1","author":"Ron","year":"1998","journal-title":"Genes Dev"},{"key":"41","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1038\/nrneph.2017.129","article-title":"Endoplasmic reticulum stress, the unfolded protein response and autophagy in kidney diseases","volume":"1","author":"Cybulsky","year":"2017","journal-title":"Nat Rev Nephrol"},{"key":"42","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1111\/bjh.16493","article-title":"Venetoclax: the first anti-myeloma agent with a reliable biomarker","volume":"18","author":"Jelinek","year":"2020","journal-title":"Br J Haematol"},{"key":"43","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1007\/s11523-023-00992-4","article-title":"Population Pharmacokinetics and Pharmacodynamics of Carfilzomib in Combination with Rituximab, Ifosfamide, Carboplatin, and Etoposide in Adult Patients with Relapsed\/Refractory Diffuse Large B Cell Lymphoma","volume":"1","author":"Goey","year":"2023","journal-title":"Target Oncol"},{"key":"44","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1038\/ncb2738","article-title":"ER-stress-induced transcriptional regulation increases protein synthesis leading to cell death","volume":"1","author":"Kaufman","year":"2013","journal-title":"Nat Cell Biol"},{"key":"45","doi-asserted-by":"publisher","first-page":"e64977","DOI":"10.7554\/eLife.64977","article-title":"Unique integrated stress response sensors regulate cancer cell susceptibility when Hsp70 activity is compromised","volume":"1","author":"Brodsky","year":"2021","journal-title":"Elife"},{"key":"46","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1158\/1541-7786.MCR-22-0843","article-title":"Non-Essential Amino Acid Availability Influences Proteostasis and Breast Cancer Cell Survival During Proteotoxic Stress","volume":"2","author":"Brodsky","year":"2023","journal-title":"Mol Cancer Res"},{"key":"47","doi-asserted-by":"publisher","first-page":"8253","DOI":"10.1073\/pnas.1118193109","article-title":"Autophagy inhibitor Lys05 has single-agent antitumor activity and reproduces the phenotype of a genetic autophagy deficiency","volume":"10","author":"Amaravadi","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"key":"48","doi-asserted-by":"publisher","first-page":"115792","DOI":"10.1016\/j.ejmech.2023.115792","article-title":"Recent advances in small molecule and peptide inhibitors of glucose-regulated protein 78 for cancer therapy","volume":"26","author":"Hu","year":"2023","journal-title":"Eur J Med Chem"},{"key":"49","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1158\/0008-5472.CAN-11-2001","article-title":"HMGB1 promotes drug resistance in osteosarcoma","volume":"7","author":"Tang","year":"2012","journal-title":"Cancer Res"},{"key":"50","doi-asserted-by":"publisher","first-page":"17163","DOI":"10.1074\/jbc.M114.558288","article-title":"Role of autophagy in cisplatin resistance in ovarian cancer cells","volume":"28","author":"Wu","year":"2014","journal-title":"J Biol Chem"},{"key":"51","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1016\/j.tips.2023.02.003","article-title":"Recent advances in targeting autophagy in cancer","volume":"4","author":"Amaravadi","year":"2023","journal-title":"Trends Pharmacol Sci"},{"key":"52","doi-asserted-by":"publisher","first-page":"3492","DOI":"10.1182\/blood-2005-11-4541","article-title":"Severe pulmonary complications in Japanese patients after bortezomib treatment for refractory multiple myeloma","volume":"10","author":"Oshimi","year":"2006","journal-title":"Blood"},{"key":"53","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jaccao.2022.12.005","article-title":"Cardiovascular Toxicity of Proteasome Inhibitors: Underlying Mechanisms and Management Strategies:State-of-the-Art Review","volume":"5","author":"Stamatelopoulos","year":"2023","journal-title":"JACC CardioOncol"},{"key":"54","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1038\/nrclinonc.2016.206","article-title":"Proteasome inhibitors in cancer therapy","volume":"1","author":"Orlowski","year":"2017","journal-title":"Nat Rev Clin Oncol"},{"key":"55","doi-asserted-by":"publisher","first-page":"123125","DOI":"10.1016\/j.lfs.2024.123125","article-title":"Bortezomib in cancer therapy: Mechanisms, side effects, and future proteasome inhibitors","volume":"35","author":"Upadhyay","year":"2024","journal-title":"Life Sci"},{"key":"56","doi-asserted-by":"publisher","first-page":"7060","DOI":"10.1021\/acs.jmedchem.0c02091","article-title":"Function, Therapeutic Potential, and Inhibition of Hsp70 Chaperones","volume":"6","author":"Chapman","year":"2021","journal-title":"J Med Chem"},{"key":"57","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1007\/s12192-022-01281-1","article-title":"Multivalent protein-protein interactions are pivotal regulators of eukaryotic Hsp70 complexes","volume":"2","author":"Gestwicki","year":"2022","journal-title":"Cell Stress Chaperones"},{"key":"58","doi-asserted-by":"publisher","first-page":"15545","DOI":"10.1073\/pnas.0506580102","article-title":"Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles","volume":"10","author":"Mesirov","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"59","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1038\/nature23647","article-title":"Orthotopic patient-derived xenografts of paediatric solid tumours","volume":"54","author":"Zhou","year":"2017","journal-title":"Nature"}],"container-title":["Oncotarget"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.28764","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,29]],"date-time":"2025-08-29T15:00:08Z","timestamp":1756479608000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.28764"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,29]]},"references-count":59,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,8,29]]}},"alternative-id":["28764"],"URL":"https:\/\/doi.org\/10.18632\/oncotarget.28764","relation":{},"ISSN":["1949-2553"],"issn-type":[{"value":"1949-2553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,29]]}}}